These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21726415)

  • 1. Crystal structures of Candida albicans dihydrofolate reductase bound to propargyl-linked antifolates reveal the flexibility of active site loop residues critical for ligand potency and selectivity.
    Paulsen JL; Bendel SD; Anderson AC
    Chem Biol Drug Des; 2011 Oct; 78(4):505-12. PubMed ID: 21726415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidating features that drive the design of selective antifolates using crystal structures of human dihydrofolate reductase.
    Lamb KM; G-Dayanandan N; Wright DL; Anderson AC
    Biochemistry; 2013 Oct; 52(41):7318-26. PubMed ID: 24053334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-guided development of efficacious antifungal agents targeting Candida glabrata dihydrofolate reductase.
    Liu J; Bolstad DB; Smith AE; Priestley ND; Wright DL; Anderson AC
    Chem Biol; 2008 Sep; 15(9):990-6. PubMed ID: 18804036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propargyl-linked antifolates are dual inhibitors of Candida albicans and Candida glabrata.
    G-Dayanandan N; Paulsen JL; Viswanathan K; Keshipeddy S; Lombardo MN; Zhou W; Lamb KM; Sochia AE; Alverson JB; Priestley ND; Wright DL; Anderson AC
    J Med Chem; 2014 Mar; 57(6):2643-56. PubMed ID: 24568657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro biological activity and structural analysis of 2,4-diamino-5-(2'-arylpropargyl)pyrimidine inhibitors of Candida albicans.
    Paulsen JL; Liu J; Bolstad DB; Smith AE; Priestley ND; Wright DL; Anderson AC
    Bioorg Med Chem; 2009 Jul; 17(14):4866-72. PubMed ID: 19560363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydrofolate Reductase Is a Valid Target for Antifungal Development in the Human Pathogen
    DeJarnette C; Luna-Tapia A; Estredge LR; Palmer GE
    mSphere; 2020 Jun; 5(3):. PubMed ID: 32581079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selectivity analysis of 5-(arylthio)-2,4-diaminoquinazolines as inhibitors of Candida albicans dihydrofolate reductase by molecular dynamics simulations.
    Gokhale VM; Kulkarni VM
    J Comput Aided Mol Des; 2000 Jul; 14(5):495-506. PubMed ID: 10896321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep-learning based repurposing of FDA-approved drugs against
    Joshi T; Pundir H; Chandra S
    J Biomol Struct Dyn; 2022 Nov; 40(18):8420-8436. PubMed ID: 33879017
    [No Abstract]   [Full Text] [Related]  

  • 9. Structural analysis of the active sites of dihydrofolate reductase from two species of Candida uncovers ligand-induced conformational changes shared among species.
    Paulsen JL; Viswanathan K; Wright DL; Anderson AC
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1279-84. PubMed ID: 23375226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structures of Klebsiella pneumoniae dihydrofolate reductase bound to propargyl-linked antifolates reveal features for potency and selectivity.
    Lamb KM; Lombardo MN; Alverson J; Priestley ND; Wright DL; Anderson AC
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7484-91. PubMed ID: 25288083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing the active site of Candida glabrata dihydrofolate reductase with high resolution crystal structures and the synthesis of new inhibitors.
    Liu J; Bolstad DB; Smith AE; Priestley ND; Wright DL; Anderson AC
    Chem Biol Drug Des; 2009 Jan; 73(1):62-74. PubMed ID: 19152636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X-Ray crystal structures of Candida albicans dihydrofolate reductase: high resolution ternary complexes in which the dihydronicotinamide moiety of NADPH is displaced by an inhibitor.
    Whitlow M; Howard AJ; Stewart D; Hardman KD; Chan JH; Baccanari DP; Tansik RL; Hong JS; Kuyper LF
    J Med Chem; 2001 Aug; 44(18):2928-32. PubMed ID: 11520201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of Receptor- and Ligand-based Models in Inverse Docking Experiments: Recognition of Dihydrofolate Reductase Using 7,8-Dialkyl- 1,3-Diaminopyrrolo[3,2-f]Quinazolines.
    Kumar SP; Jasrai YT; Pandya HA
    Curr Comput Aided Drug Des; 2016; 12(1):15-28. PubMed ID: 26725591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate-synthesizing enzyme system as target for development of inhibitors and inhibitor combinations against Candida albicans-synthesis and biological activity of new 2,4-diaminopyrimidines and 4'-substituted 4-aminodiphenyl sulfones.
    Otzen T; Wempe EG; Kunz B; Bartels R; Lehwark-Yvetot G; Hänsel W; Schaper KJ; Seydel JK
    J Med Chem; 2004 Jan; 47(1):240-53. PubMed ID: 14695838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2,4-Diamino-5-(2'-arylpropargyl)pyrimidine derivatives as new nonclassical antifolates for human dihydrofolate reductase inhibition.
    Algul O; Paulsen JL; Anderson AC
    J Mol Graph Model; 2011 Feb; 29(5):608-13. PubMed ID: 21146434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural studies on bioactive compounds. 30. Crystal structure and molecular modeling studies on the Pneumocystis carinii dihydrofolate reductase cofactor complex with TAB, a highly selective antifolate.
    Cody V; Chan D; Galitsky N; Rak D; Luft JR; Pangborn W; Queener SF; Laughton CA; Stevens MF
    Biochemistry; 2000 Apr; 39(13):3556-64. PubMed ID: 10736154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations of inhibitor kinetics for Pneumocystis jirovecii and human dihydrofolate reductase with structural data for human active site mutant enzyme complexes.
    Cody V; Pace J; Makin J; Piraino J; Queener SF; Rosowsky A
    Biochemistry; 2009 Mar; 48(8):1702-11. PubMed ID: 19196009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tea polyphenol epigallocatechin-3-gallate inhibits ergosterol synthesis by disturbing folic acid metabolism in Candida albicans.
    Navarro-Martínez MD; García-Cánovas F; Rodríguez-López JN
    J Antimicrob Chemother; 2006 Jun; 57(6):1083-92. PubMed ID: 16585130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-ray crystallographic studies of Candida albicans dihydrofolate reductase. High resolution structures of the holoenzyme and an inhibited ternary complex.
    Whitlow M; Howard AJ; Stewart D; Hardman KD; Kuyper LF; Baccanari DP; Fling ME; Tansik RL
    J Biol Chem; 1997 Nov; 272(48):30289-98. PubMed ID: 9374515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structures of wild-type and mutant methicillin-resistant Staphylococcus aureus dihydrofolate reductase reveal an alternate conformation of NADPH that may be linked to trimethoprim resistance.
    Frey KM; Liu J; Lombardo MN; Bolstad DB; Wright DL; Anderson AC
    J Mol Biol; 2009 Apr; 387(5):1298-308. PubMed ID: 19249312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.